Literature DB >> 10930829

Statistical methods for the objective design of screening procedures for macromolecular crystallization.

D Hennessy1, B Buchanan, D Subramanian, P A Wilkosz, J M Rosenberg.   

Abstract

The crystallization of a new macromolecule is still very much a trial-and-error process. As is well known, it requires the search of a large parameter space of experimental settings to find the relatively few idiosyncratic conditions that lead to diffraction-quality crystals. Crystallographers have developed a variety of screens to help identify initial crystallization conditions, including those based on systematic grids, incomplete factorial and sparse-matrix approaches. These are somewhat subjectively formulated based on accumulated data from past crystallization experiments. Ideally, one would prefer as objective a procedure as possible; however, that requires objective methods that incorporate a broad source of crystallization data. The Biological Macromolecular Crystallization Database (BMCD), a repository of all published crystallization conditions, is an obvious source of this data. This database has been augmented with a hierarchical classification of the macromolecules contained in the BMCD as well as extensive data on the additives used with them. A statistical analysis of the augmented BMCD shows the existence of significant correlations between families of macromolecules and the experimental conditions under which they crystallize. This in turn leads to a Bayesian technique for determining the probability of success of a set of experimental conditions based on the data in the BMCD as well as facts about a macromolecule known prior to crystallization. This has been incorporated into software that enables users to rank experimental conditions for new macromolecules generated by a dense partial factorial design. Finally, an additional advantage of the software described here is that it also facilitates the accumulation of the data required for improving the accuracy of estimation of the probabilities of success - knowledge of the conditions which lead to failure of crystallization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930829     DOI: 10.1107/s0907444900004261

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  8 in total

1.  Laboratory scale structural genomics.

Authors:  Brent W Segelke; Johana Schafer; Matthew A Coleman; Tim P Lekin; Dominique Toppani; Krzysztof J Skowronek; Katherine A Kantardjieff; Bernhard Rupp
Journal:  J Struct Funct Genomics       Date:  2004

2.  Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa.

Authors:  Saul R Trevino; J Martin Scholtz; C Nick Pace
Journal:  J Mol Biol       Date:  2006-10-13       Impact factor: 5.469

Review 3.  Unmet challenges of structural genomics.

Authors:  Maksymilian Chruszcz; Marcin Domagalski; Tomasz Osinski; Alexander Wlodawer; Wladek Minor
Journal:  Curr Opin Struct Biol       Date:  2010-08-31       Impact factor: 6.809

4.  Cosolvent-induced transformation of a death domain tertiary structure.

Authors:  Tsan Xiao; Kevin H Gardner; Stephen R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

5.  The MORPHEUS protein crystallization screen.

Authors:  Fabrice Gorrec
Journal:  J Appl Crystallogr       Date:  2009-11-07       Impact factor: 3.304

6.  Using isoelectric point to determine the pH for initial protein crystallization trials.

Authors:  Jobie Kirkwood; David Hargreaves; Simon O'Keefe; Julie Wilson
Journal:  Bioinformatics       Date:  2015-01-07       Impact factor: 6.937

Review 7.  Crystallization screening: the influence of history on current practice.

Authors:  Joseph R Luft; Janet Newman; Edward H Snell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-06-27       Impact factor: 1.056

8.  Analysis of crystallization data in the Protein Data Bank.

Authors:  Jobie Kirkwood; David Hargreaves; Simon O'Keefe; Julie Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.